Figure 2.
Effect of TRAIL on differentiation of adherent PBMCs into functional osteoclasts. Adherent PBMCs were left untreated (without cytokines) or cultured in the presence of TRAIL and with RANKL plus M-CSF with or without TRAIL. After 10 days cells were analyzed for osteoclastic differentiation. (A) Representative fields of the cultures, treated as indicated, after TRAP staining (magnification, × 10; numerical aperture of the objective lens [NA], 0.25). Similar results were observed in 7 independent experiments performed in duplicate. (B) Magnification of a representative TRAP-positive multinucleated cell (i), and a representative field of RANKL plus M-CSF-treated cultures observed by light microscopy (ii) and by fluorescence microscopy after DAPI staining (iii). *Polynucleated cells characteristic of RANKL plus M-CSF cultures. Original magnification and NA: i, × 40 0.75 NA; ii-iii, × 20, 0.25 NA. In panel C, adherent PBMCs were plated on an artificial bone matrix slide and were cultured with RANKL plus M-CSF, in the absence or presence of TRAIL (10 ng/mL), as indicated. After 12 days, the slides were fixed and stained, and resorption was determined by examining pit formation under a light microscope (magnification, × 20; NA, 0.40). Representative fields are shown. (D-E) Cultures were treated as indicated and the number of TRAP-positive multinucleated cells containing 3 or more nuclei was scored. Data represent the means ± SD of 3 to 7 different experiments (*P < .05, compared with RANKL plus M-CSF).